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1. INTRODUCTION 
The rncchanisms which regulate G protein-receptor 
function are diverse and include rapid cvcnts which lcad 
to receptor/G protein uncoupling as well as more long 
term events which eventually result in receptor degrada- 
tion [ 1,2]. One of the major mec!lanisms implicated in 
the initial rapid uncoupling phase of desensitization ap- 
pears to involve receptor phosphorylation. Utilizing the 
/3z-adrenergic receptor-coupled a enylyl cyclasc system 
as a model it has been shown that receptor phosphoryla- 
tion is mediated by at least wo distinct protein kinases. 
The CAMP dependent protein kinase phosphorylates 
the &-adrenergic receptor (&AR) at two distinct sites 
and may be largely responsible for mediating desen- 
sitization observed at low agonist concentrations [3-51. 
In contrast, the @-adrenergic receptor kinase @ARK) 
phosphorylates the P2AR to a stoichiometry of - 8 mol 
phosphate/m01 receptor and appears to mediate agonist- 
specific desensitization observed at high agonist con- 
centrations is-71. 
&UN is a ubiquitous cycosolic enzyme which spe- 
cifically phosphorylates the activated form of the p- 
adrenergic and related G protein-coupled receptors 
[7-91. @ARK, purified from bovine brain, consists of a 
single subunit of 80 000 Da which is not activated by a 
wide variety of kinase stimulatory agents [7]. Recently, 
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we have isolated a cDNA encoding bovine PARK [ 10). 
This cDNA encodes a protein of 689 amino acids (79.6 
kDa) with a centrally localized catalytic domain which 
has highest homology with S6 kinnse, the CAMP de- 
pcndcnt protein kinase and protein kinase C. When in- 
serted into a mammalian expression vector and ex- 
pressed in COS-7 cells the PARK cDNA encoded a pro- 
tein which specifically phosphorylatcd the agonist- 
occupied form of the Pz-adrcnergic receptor and more 
weakly the light activated form of rhodopsin [IO], 
While significant work has been performed on bovine 
PARK little is known about the human form of this en- 
zyme. In this work, WC have used the bovine @ARK 
cDNA to screen a human retinal library and isolate the 
cDNA encoding human PARK. The human PARK gene 
was then localized to the long arm of chromosome 11 by 
Southern hybridization analysis of a rodent-human 
hybrid panel. 
2. MATERIALS AND METHODS 
2.1 , Isokutinri und sequeticing of the hutnat! pARA’ cRNA 
A human retinal cDNA library (IO” total clones) was screened with 
two ‘*P labeled oligonuclcotide probes which had previously been 
used to isolate the bovine PARK cDNA ([IO], oligos no. I, 2)$ The 
probes were hybridized for 48 h at 42°C in a solution containing 6 x 
saline sodium citrate (SSC), 5 x Denhardt’s solution, 0.1% sodium 
dodccyl sulfate (SDS) and 100 &ml denatured salmon sperm DNA. 
The filters were washed initially with 2 x SSC, 0.1% SDS at 60°C and 
the stringency was thei, increased by decreasing the salt concentra- 
tion. A total of 5 clones which hybridized with both oligos at high 
stringency (0,2 x SSC, 6OOC) were isolated. The isolated cDNAs were 
excised with EC&I and inserted into the vector pSP 65 for sequencing+ 
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I 
: 
PWVOGWL~MKOVFPDLTOPYtGEICOHLRGPVPPn 
::ChTl5AThCtGAtAAGifCACACCG~?lTGtCAGPGGAAGAA~G~GGhGt7thhCA?CCACt7GAttAlGAA~~kC?TCAGCG7GCA7CGCATCAT7GGGC~tC~CGGC?~7~GCGAG II* 
P : g!?enPt R P t 0 nI( )Pv c L H I IIL 7 Ii H D r 6 VW n r!GrGGf’G6 zo4 
G’it:A?6BG:G~t6GAkGtGlGheACAGGChhGATGthCGCtATGkAG?GtCYGGACA~AAAGCGCATtAAGAYGAA6t~GQC6GAGACtCTUGCCC7GAACGAGt6tA7CA7GC7t7CG 610 
VYGC~~ADSG~n~h~KCLBI~~l~NN~C67LALN~A~~LS 244 
A 
t~G~tA~:A~TG~~G~t:~t~~A~~tA?7~?t76tATG7CA~ACGCG~?tCAtACGCtAGAtAACC?thGC?TtA~Ct~CGACtTtA7CAAC6G7CGCOACtTGCAC?AtCACC7C?Ct c50 
* * IY t t4 J I h P W 7 BGK L I P I LD LN # G G D LH 7 M L S 214 
ChCtAfC~GCft:~tTCACA6CC?GACATCt~CT~C?Al6CGGCtGAGATtA7CCTGGGtC?GCAGtACATGCACAACtCC??tG7GGTC7ACCG~GACt7CAACCCAGCCAACA?CCT7 
OWGVFSRADMRP Y A A K I Z L G Li t It ii H r( R F V V Y W D L I4 I’ A td II L ‘% 
tTG6AtGAGChfCCCCACG;GCG~A?C?CGGACCfGtGCtClCGCC~6TCAC7?C?tCAAGAACAAGCtCCA7GCCAGCG~GGCCACCCAtGGCTACA7GCC7tCCGAGGTtC7GCAGAAG 
L B e n G &I v R IS D L G LA C DF S n NK P II A S V li 7 H C r t+ A D E V LON ‘3: 
G~CC~GG~ClhCGACAGChttCC(GAC?CG~?CTC7C~CGGG7CCA~GC~C7?CAAG~~GCTGCCGGGGCACA~CC~CT~CC~CC~C~tAAGACCAAAGAChAGCA7GA6ATCCAtCGt 
r c I I A 5 u P s L t c n I. F n L L R a Ii Rt~DMHCXDR ‘X 
AfGAFGt?GhtGAl~GCCGTGGAGCTGCCCCAC~CC?TC~CCtC~GAACYACAC~tCC?CC?GCACGGC~TGC~~GCAC~~CGA?C7tAACCCCAGAT~CGCCTGtC?GGCCCGAGCCGC7 
n t t f x A V r, LPDS~SPEL~5LLEGLLOhGVWRRtCCLGHGA “::: 
CAC6ACe7eAAhGhGhSCCCCY?TTTCC6C~CCC?CCACTCGCA6~TGC?CTTC7TGCAGACC~ACCC?CCCCCCC7GA7CCCCCCACGAGC6CACG7GAACGCCGCCCACCCC7TCGAC 1%$9 
OPVKESPF FRSLDWOnV FLOHIPPPLXPBRCeVHAhDAFD 484 
8 
A71CGETC:l?CCATGAGOA~~ACACAA~ACGAA?CAAGT~AC?GCACACTGAYCAGGA~C~C~ACCGCAACT~CCCCCTCACCA7CTCCOAGCCGTGGCAGCAGGAGGTCGCAGAG~~7 
: t S F I3 E E D 7 It G I K LLDSDOE L Y R It F P L 7 ~sERWOOEVAC~ ‘::: 
G~C?~CC~CA~ChSCAACCCTGAGACAGACCCGCTGGAGGCTCGCAAG~AAGCCAAGAACA~GCAGCTCGGCCATGAGCAAGACTACGCCCTGGGCAAGCACTGCA~C4~CC~TG~CT~C 
I H A & 7 D R L C A R K K A K N KO L C 14 E ED Y A L t K D C ‘3:: 
T 
ATGTCCAAGATGCECAACCCCTTtCTGACCCAGTGCCAGCG~CGGTACTTCTACCTGTTCCCCAACCGCCTCGAGTGGCGGGGCGAGGGCGhGGCCCCCCAGAGCCTCCTGACCATGGAG 1919 
n s hWGWPF LTQWQRRYFYLF PNRLCWRGEGEAPOSLL7biE 604 
GAGA?CCAtTCCGTGCACCACACCCACATCACATCAAGGACCGCA~GTGCCTGCTCCTCAAGATCCCCGGTGCCA~ACAG?7C4TTTTGCAGTGCGATAGCGACCCTGAGCTCGTGCAGTGGbAG 2019 
f I 0 s v E E 1 0 IKEBKCLLLKI RGGKOFILOCDSDPELWOYK 644 
V 
AACCASCSCCCCtACSCCTACCGCCAOEAtC7GGTGCAGCGGGTCCCCAAGATCA~CAAC~~CCCCCGC7CGCCCC7GGTGCAGCTCAGCAAGGTGCCCCTCGTCCAGCGCGGC 
K E L R D A 1 R E A a 0 LVORVPKM I( N ti P R S P V V L: f S K VP L VO R C ‘Z 
1 
A~TC~CA~CS~CC~TCACCCCCCCCACCCGCCTTTTATAAACCTCTAATTTATTTTCTCGAATTTTTATT~TTTGTTTTCCCCCCAAGCGAAAAGGTTTTATTTTGTAATTATTGTGATT 2279 
. 609 
. 
TCCCCTGCCCCCRCCCTGtCcCAGCTCCtCCCGRnOCCCCCGCTTGCCTCGGCTCCTGCTGCACCAACCCAGCCCCTGCCCGGCGCCCTCTGTCCTGACTTCAGGGGCTGCCCGCTCCCA 2399 
CTGTCTTCCTGTtCGCGAACAGCACAGCCCTCCCGCCCCTTCCCCCAGGGATGATGCCACACCAAGCT~TCCCACCCTCCGCTCTGTGGGCTGCACTTGTCCCATGGCACTGTGCGTCGC 2519 
CCATCCCCCCTCACCACGGGCAGGCACAGCACACCGATCCGACTTGAA~TTTCCCACTGCACCCCCTCC~GCTGCAGAGGGGCAGGCCCTOCACT~TCCTGCTCCACAOTGTTGGCGA~~A 2639 
GCACCtCCCCGT7CTcTCCCTG~CCGTCAAGG~TCCCAC~GTG4CTCGG~CTCCTGTGCCCTTATTCACGAAAAGCCTCTG’~G~CACTGGCTGCCTCCACTCCcAC~STcCCTGACAC~GC 2759 
CG~CCTTCCCTGACACAGTGCCATT~CC~CCBCGTGCTGCTA~CCTCCCTGCTCTCCCCTCT~~GCCCCAACCCCCAGCACCCGC~CTCAGGGACCACAGCAAGGCACCTGCAGG?~GGGC 2B7P 
CATAC?CSCC;CCCCTCGCCTCACG?CTCGCTCGCTGATGCTGCGCTCGGTGCGACCCCA’~CTGCCC~GGAC~GGCCCti~CCAti~~~GGGCGG~~hG~ACA~CAA~~AGGCTGtiCT~C~~CCTAT 2999 
cAC?~T~CCCCCCh~CCTCCCCCA~r~AGTGTACCCCCCCCCAGACTC~~CCAGCCCCACAGCCCACGT~CTGTCA~?GCCCCCGCC’~CGCCCA~~~CA’~~~~C~~T~T~~~A~~~~~TCTG~ 3119 
CTCTCfGTG7CCACTCT 3136 
Fig. I, Nucleotide and deduced amino acid sequence of human PARK. The nucleotides and amino acids are numbered on the right hand side, 
Shown also are the amino acids which differ in the bovine PARK sequence, in total there are 14 differences, six of which are conservative substitu- 
tions. 
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3. RESUL’I’S AND BISCUSSCQN 
10” independent clones from a human retinal cDNh 
library were initially screened with two labeled bovine 
PARK oligonucteotidcs, A total of 5 clones which 
hybridized with both oligonucleoride probes at high 
stringency (0.2 x SSC, 6O’C) were isolated. The clones 
were purified and when excised with EcoRI four of the 
clones yielded a sin& insert band ranging in size from 
I .3 ta 33 lets, TPhc Flfrh clnne when rxeisrd yieldrd two 
DNA bands af 6dS elf 0.8 kb due to the prcaencr af 
nn &&Rt xitc within rhc inserl. The 0,35, a.8 and - 2.8 
kb of the 3,s kb clanc WPC actquenecd cm both strands 
and compared to the sequence of bavinc BARK (Filg. I), 
The open reading t”rams of the human @ARK cDNA en- 
codes a protein of 689 amino acids which has 9&O’% 
amino acid and 92.5% nueleotidc identity IQ bovine 
BARK. Wirh conaervnrivc amino acid substitutions the 
hamelogy increases CB 98.8%. The eequenccd portion 
of 11~ human BARK clone contains 107 bp of 5’ WI- 
trtlnalntcd sequenec which has - !XIoZa homology with 
the! 84 bp of 5’ untranslated sequence from the bovine 
BARK cDNA [IO], This homology Is largely due to the 
GC richness of both 5’ untranslated scquenees (82% 
GC for IIUIIXIII, 86oPo for bovine), In addition, the 3’ 
untranslated regions of the human and bovine clones 
contain a potentially interesting stretch of - 125 bp 
which are 9SpTe identical at the nucleotide level, This 
srretch starts immediarcly after the stop codon in the 
human clone (bp 2178-2304) and 24 bases after the stop 
codon in the bovine clone (2180-2307). The 3’ localizn- 
cion and hi&h degree of conservation of this region sug- 
gcsts fhac it may play some regulatory role in translation 
of the @ARK message [14]. 
More than 20 rodent-human hybrids were then cxam- 
Fig. 2. Presence of the PARK gene in 17 rodent-human hybrids. A completely stippled box indicates that the hybrid named in the left column con- 
tains the chromosome indicated in the upper row; lower right stippling indicates presmce of the long arm (or part of the long arm, indicated by 
a smaller fraction of stippling) of the chromosome shown above the column; upper left stippling indicates presence of the short arm (or partial 
short arm) of the chromosome listed above the column; no stippling indicates the absence of the chromosome iisted above the column. The column 
for chromosome I1 is boldly outlined and stippled to highlight correlation of presence of this chromosome (or region of chromosome) with presence 
of the probe. The pattern of retention of the PARK gene in the panel is shown in the column to the right of the figure where presence of the probe 
in the hybrid is indicated by a stippled box with a plus sign and absence of the probe is indicated by an open box enclosing a minus sign. 
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incd for the presence of the BARK locus by hybridisa- 
risn of B radialnbcled human ljARl;c probe to &x~Rl 
cleaved hybrid and conrrol DNAs immobilized on nylon 
Filters. Results of resting of rhc entire panel dcmon- 
srrated fhal rhc human @ARK locus was prcsenr only in 
hybrids retaining chromosome 11 and was absent in all 
hybrids which did not contain chromosome I I as sbm- 
marized in Fig. 2. An cxamplc of rcsul~ of such 
hybridization scudics arc shown in Fig. 3. The human 
BARK specific 15 kbp EcoRI fragment is present in the 
human DNA (lane 2) and each of the hybrids shown 
(lanes 3-8); a mouse specific EcoR[ fragment (> 23 kbp) 
is derectcd in the mouse DNA (hnc 1) and is also prcs- 
cnt in each of the hybrid DNA containing lanes. Each 
of the hybrids in lanes 3-8 retains an entire or partial 
chromosome 11 as detailed in the legend to Fig. 3. 
Fig, 3 also illustrates regional localization of the 
PARK gene since hybrids in lanes 5 and 8 retain 1 Iq [12] 
and the hybrid (734) in lane 7 retains a derl 1 
(11 pter+ 1 lq23::XqSXqter) 1151. A daughter clone 
derived by selection of the hybrid 734 in B-thioguaninc 
(to eliminate the der 11 chromosome by selective killing 
of cells retaining the active HPRT gene on the X 
chromosome derived portion of the derll) [16] was 
negative for the PARK gene (not shown). Thus the 
@ARK gene must localize to the portion of chromosome 
11 (11ccn+ 1 lq23) which is common to the hybrids in 
lanes 5-8. The final regional localization of the /?ARK 
gene is illustrated in Fig. 4 which provides a sketch of 
partial chromosome 11s retained in @ARK positive 
hybrids. A PARK negative hybrid, CE4 (Souzhern data 
not shown), retained chromosome region 1 lq13-1 lqter 
with a break in the BCL-I locus [12], eliminating the 
region 1 lq13-1 Iqler. Therefore, the /3ARK gene is 
located in d-x narrow chromosomal region between the 
centromere of chromosome 11 and the portion of 1 lql3 
carrying the BCL-I locus, as indicated by the bracketed 
overlap region in Fig. 4. 
Amplification of a cluster of loci at 1 lq13 usually in- 
p&IRK + + + + 11 
r?y. 4. Regional Iocnliaariun 0r the /I,lF-!K locus. Ding-wn of 
chrambromc I I wiIh portions of ehramoname I I rWnhetl by various 
hybrids skarhcd on rhc I&. The do~~cd portion df Ihe line reprcrcn. 
ling hybrid 734 indieateri unscr~aimyofrlie disml cndpoinl which run. 
~31 bs dsrcrn:in::l cxxtlp rp:og:ncrii’nlly. TItc pmcne of the lf,iRK 
lucur in cash of the hybritln is indisnrctl below by R plus sign; on the 
far Ich the nvcrlnp rcpian indicntcs rhc rqian of clmmoromc I I 
C~IIIIWW m ~hr dARK poxhive hybrids. Thus lhc 6ARK gene rcrirlrr 
wirhin this region, Ilcen-*llql3. 
eluding the EL-l, HSTFI, and /NT2 loci has been 
observed in some human tumors [17-211. Since the 
location of the mouse Bark gene (Benovic er al., in 
preparation) suggests that the human aARK gene most 
likely also maps near 1 lq13, mammary carcinoma 
derived lines carrying amplified BCL-I/HSTFI/?NTZ 
loci were tested for amplification of the /IARK locus. 
The PAX/(: locus was not amplified in any of the five 
lines tested (not shown). 
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